INVO Fertility, Inc. IVF
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2008-11-11
INVO Fertility, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | — | — | — | 59.7% | 96.5% |
| Operating margin | -105.8% | -101.0% | -224.0% | -1292.5% | -125.4% |
| Net margin | -340.9% | -141.1% | -266.0% | -1324.8% | -160.0% |
| FCF margin | -103.2% | -48.1% | -172.1% | -804.4% | -154.9% |
| Return on assets | -115.3% | -20.1% | -43.4% | -265.4% | -63.6% |
| Return on equity | -322.8% | -73.6% | -899.9% | 1114.2% | -91.0% |
| Debt / equity | 0.12× | 0.59× | — | — | — |
| Current ratio | 0.27 | 0.07 | 0.16 | 0.18 | 5.03 |
| Revenue growth | 4.3% | 117.2% | 267.4% | -80.2% | 301.1% |
Source: SEC EDGAR filings · CIK 0001417926 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.